News|Videos|January 9, 2024
Orbis CEO and president gives insight into 2024 plans
Author(s)David Hutton
David Hutton of Ophthalmology Times talks with Derek Hodkey, CEO and president of Orbis International, about 2023 in review as well as plans for the company moving into 2024.
Advertisement
David Hutton of Ophthalmology Times talks with Derek Hodkey, CEO and president of Orbis International, about 2023 in review as well as plans for the company moving into 2024.
Video Transcript
Editor's note - This transcript has been edited for clarity.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Retina Society 2026: MCO-010 optogenetic therapy maintains visual acuity gains through 4 years in advanced RP
2
Manju Subramanian, MD: anti-VEGF linked to kidney function decline
3
Retina Society 2026: Medium-dose OCU410 gene therapy cuts geographic atrophy progression by up to 32% in phase 2 trial
4
Retina Society 2026: Could statins reduce PVR risk after RD repair?
5









